Канал: CRISPR Hassan

CRISPR One Time Treatment is Superior to Alternatives

CRISPR One Time Treatment is Superior to Alternatives

NTLA Has Competitors for NTLA-2001?

NTLA Has Competitors for NTLA-2001?

Intellia Gets Fast Tracked by FDA

Intellia Gets Fast Tracked by FDA

Don't Sleep on NTLA-2002

Don't Sleep on NTLA-2002

CRISPR November 2024 Updates

CRISPR November 2024 Updates

Intellia Releases New CRISPR Data

Intellia Releases New CRISPR Data

TIME Declares CRISPR as Best Invention of 2024

TIME Declares CRISPR as Best Invention of 2024

Markets Are Soaring! Future of CRISPR?

Markets Are Soaring! Future of CRISPR?

Vertx & CRISPR Tx have begun infusing patients

Vertx & CRISPR Tx have begun infusing patients

CNN Interviews Doudna & CRISPR

CNN Interviews Doudna & CRISPR

Vertex Drops Big News on CASGEVY CRISPR

Vertex Drops Big News on CASGEVY CRISPR

Intellia Data Release for NTLA-2001

Intellia Data Release for NTLA-2001

Vertex Release Startling Data for CASGEVY

Vertex Release Startling Data for CASGEVY

CRISPR Tx Expands on In-Vivo

CRISPR Tx Expands on In-Vivo

Moderna Failed Biotech

Moderna Failed Biotech

Moderna Breaks Off with CRISPR

Moderna Breaks Off with CRISPR

Regeneron Partners with Mammoth CRISPR

Regeneron Partners with Mammoth CRISPR

CRISPR CEO Latest Interview

CRISPR CEO Latest Interview

CRISPR Tx Updates April 2024 (Part 1)

CRISPR Tx Updates April 2024 (Part 1)

BEAM Moves Forward with CRISPR In-Vivo

BEAM Moves Forward with CRISPR In-Vivo

CRISPR Pig Kidney Xenotransplanted

CRISPR Pig Kidney Xenotransplanted

NTLA Phase 3 Started Dosing

NTLA Phase 3 Started Dosing

Huge Private Insurer Now Covering CASGEVY

Huge Private Insurer Now Covering CASGEVY

Jennifer Doudna TED Talk 2024

Jennifer Doudna TED Talk 2024

CRISPR & HIV

CRISPR & HIV

CASGEVY Getting Push Back from U.K.

CASGEVY Getting Push Back from U.K.

Can CASGEVY be approved by Medicaid in U.S. States?

Can CASGEVY be approved by Medicaid in U.S. States?

CRISPR on Front Page of Wall Street Journal

CRISPR on Front Page of Wall Street Journal

Beam Therapeutics is Burning Cash

Beam Therapeutics is Burning Cash

Goldman Sachs Slashes $NTLA Price

Goldman Sachs Slashes $NTLA Price

Intellia Tx Firing from all Cylinders

Intellia Tx Firing from all Cylinders

CRISPR Tx Business Updates - Best CRISPR Company?

CRISPR Tx Business Updates - Best CRISPR Company?

CAR-T CRISPR May Get Approved Sooner by the FDA?

CAR-T CRISPR May Get Approved Sooner by the FDA?

CRISPR Tx Diluting Stock?

CRISPR Tx Diluting Stock?

Europe Approves CASGEVY CRISPR

Europe Approves CASGEVY CRISPR

CRISPR & Legacy Media

CRISPR & Legacy Media

CRISPR Tx Failed its Diabetes Program with ViaCyte

CRISPR Tx Failed its Diabetes Program with ViaCyte

CRISPR & World Cancer Day

CRISPR & World Cancer Day

NTLA is Going to Shock the CRISPR World

NTLA is Going to Shock the CRISPR World

BEAM Upgraded by JP Morgan, Up 17% in a Day

BEAM Upgraded by JP Morgan, Up 17% in a Day

Prime Medicine Fraud? CRISPR Companies Stealing $?

Prime Medicine Fraud? CRISPR Companies Stealing $?

CRISPR Future Applications

CRISPR Future Applications

CRISPR 2024 Breakthrough Technology

CRISPR 2024 Breakthrough Technology

BEAM Tx CRISPR Highlights 2024

BEAM Tx CRISPR Highlights 2024

FDA Approves TDT CASGEVY

FDA Approves TDT CASGEVY

Vertex Updates on CASGEVY

Vertex Updates on CASGEVY

The CRISPR Revolution

The CRISPR Revolution

BREAKING! Kingdom of Saudi Arabia Approves CRISPR CASGEVY

BREAKING! Kingdom of Saudi Arabia Approves CRISPR CASGEVY

Caribou Highlights for CRISPR in 2024

Caribou Highlights for CRISPR in 2024

Intellia 2024 Highlights

Intellia 2024 Highlights

ChatGPT & CRISPR

ChatGPT & CRISPR

What do Investors Expect from CRISPR?

What do Investors Expect from CRISPR?

What's Next for CRISPR Tx?

What's Next for CRISPR Tx?

CRISPR Predictions for 2024

CRISPR Predictions for 2024

CRISPR Morals & Ethics

CRISPR Morals & Ethics

CRISPR is the Breakthrough of the Year

CRISPR is the Breakthrough of the Year

CRISPR Hits Mainstream Social Media! Happy Holidays!

CRISPR Hits Mainstream Social Media! Happy Holidays!

Ark Invest Were Right on CRISPR

Ark Invest Were Right on CRISPR

CRISPR Tx Leadership Leaves Company

CRISPR Tx Leadership Leaves Company

Saturday Night Live on CRISPR

Saturday Night Live on CRISPR

Is This CRISPR 2.0?

Is This CRISPR 2.0?

CRISPR Casgevy 2.2$ Million per Patient

CRISPR Casgevy 2.2$ Million per Patient

U.S. President Biden Congratulates CRISPR

U.S. President Biden Congratulates CRISPR

BREAKING! The FDA Approves CRISPR.

BREAKING! The FDA Approves CRISPR.

BREAKING NEWS! Bahrain approves CRISPR Exa-Cel

BREAKING NEWS! Bahrain approves CRISPR Exa-Cel

The CRISPR Era Is Here

The CRISPR Era Is Here

Will FDA Decline Exa-Cel CRISPR?

Will FDA Decline Exa-Cel CRISPR?

"S" Curve of CRISPR Technology

"S" Curve of CRISPR Technology

Intellia Dive Deep

Intellia Dive Deep

Don't Sleep on Intellia - Big Win in Europe

Don't Sleep on Intellia - Big Win in Europe

CRISPR Enters in a New Era

CRISPR Enters in a New Era

BREAKING NEWS! CRISPR Approved to Dose Patients.

BREAKING NEWS! CRISPR Approved to Dose Patients.

CRISPR Tx & In-Vivo Success

CRISPR Tx & In-Vivo Success

What happens now with Exa-Cell & the FDA

What happens now with Exa-Cell & the FDA

FDA Gets the Approval for Exa-Cel

FDA Gets the Approval for Exa-Cel

Intellia Gets Approved by the FDA

Intellia Gets Approved by the FDA

CRISPR can extend Lifespan

CRISPR can extend Lifespan

Intellia keeps Winning at this game

Intellia keeps Winning at this game

Intellia develops partnerships

Intellia develops partnerships

CRISPR companies are undervalued

CRISPR companies are undervalued

Exa-cel Advisory Committee Meeting (AdComm)

Exa-cel Advisory Committee Meeting (AdComm)

CRSPR Recap Week of 15th September

CRSPR Recap Week of 15th September

BEAM doses their first patient.

BEAM doses their first patient.

The New Yorker CRISPR

The New Yorker CRISPR

Intellia Keeps Winning Always

Intellia Keeps Winning Always

Papayas & Bananas CRISPR

Papayas & Bananas CRISPR

Google & Ginkgo Partnership

Google & Ginkgo Partnership

Graphite Bio is Done $GRPH

Graphite Bio is Done $GRPH

Caribou Q2 2023 Business Update

Caribou Q2 2023 Business Update

$BEAM Business Update

$BEAM Business Update

Intellia $NTLA Business Update

Intellia $NTLA Business Update

CRISPR Tx Business Update

CRISPR Tx Business Update

CRISPR Foods Available Today

CRISPR Foods Available Today

CRISPR Cas9 Increases Food Shelf-Life

CRISPR Cas9 Increases Food Shelf-Life

X has now Replaced Twitter

X has now Replaced Twitter

Gene Editing: A Primer

Gene Editing: A Primer

Caribou CB-010 Destroys Competition!

Caribou CB-010 Destroys Competition!

Pfizer Invests in Caribou

Pfizer Invests in Caribou

Currency Conversion for Trades may be Robbing your Money

Currency Conversion for Trades may be Robbing your Money

Cusp of an era of astonishing innovation

Cusp of an era of astonishing innovation

NTLA-2002 Wins

NTLA-2002 Wins

FDA Approves to Review Exa-Cel CTX001

FDA Approves to Review Exa-Cel CTX001

Dr. Liu Lecture Part #2

Dr. Liu Lecture Part #2

Dr. Liu Lecture Part #1

Dr. Liu Lecture Part #1

Scribe & Eli CRISPR Partnership

Scribe & Eli CRISPR Partnership

FDA Expected to Approve CRISPR Exa-Cell

FDA Expected to Approve CRISPR Exa-Cell

First CRISPR-Edited Salad is Here

First CRISPR-Edited Salad is Here

Walter Isaacson CRISPR

Walter Isaacson CRISPR

$CRSP Cuts R&D Expenses

$CRSP Cuts R&D Expenses

CRISPR Data Does Not Lie

CRISPR Data Does Not Lie

Buy $CRSP ?

Buy $CRSP ?

Markets Status Let's Talk

Markets Status Let's Talk

Wall Street Journal says Hospitals are not ready for CRISPR

Wall Street Journal says Hospitals are not ready for CRISPR

Caribou Slams Dunk with CB-012

Caribou Slams Dunk with CB-012

Banker predicts Exa-Cel CTX001 to be FDA Approved

Banker predicts Exa-Cel CTX001 to be FDA Approved

CRISPR Tx CEO Interview

CRISPR Tx CEO Interview

TED Radio on CRISPR

TED Radio on CRISPR

CRISPR Tx & FDA

CRISPR Tx & FDA

$DNA Keeps Selling

$DNA Keeps Selling

Caribou Enrolls more Patients for ANTLER

Caribou Enrolls more Patients for ANTLER

$CRSP Keeps Winning

$CRSP Keeps Winning

CRISPR Discussed on Joe Rogan

CRISPR Discussed on Joe Rogan

CRISPR Companies Should Not Sell

CRISPR Companies Should Not Sell

Don't Sleep on NTLA-2002

Don't Sleep on NTLA-2002

CRISPR 2.0

CRISPR 2.0

Vertex Shutting Down ViaCyte and CRISPR Tx program?

Vertex Shutting Down ViaCyte and CRISPR Tx program?

Caribou Earnings 2022 Report

Caribou Earnings 2022 Report

Caribou vs CRISPR Tx

Caribou vs CRISPR Tx

Why NTLA FDA Approval Matters

Why NTLA FDA Approval Matters

Best Website for CRISPR Resources

Best Website for CRISPR Resources

NTLA Gets FDA Approval

NTLA Gets FDA Approval

Martin Shkreli Reviews NTLA CRISPR

Martin Shkreli Reviews NTLA CRISPR

CRISPR Tx Earnings Report

CRISPR Tx Earnings Report

The Next $Trillion Company

The Next $Trillion Company

Genomic Revolution

Genomic Revolution

$CRSP will Skyrocket in Price $

$CRSP will Skyrocket in Price $

New Dr. Zhang CRISPR Company

New Dr. Zhang CRISPR Company

CTX001 Clinical Hold in the Past

CTX001 Clinical Hold in the Past

The Future of CRISPR

The Future of CRISPR

Vertex is huge on CRISPR

Vertex is huge on CRISPR

Bill Gates CRISPR

Bill Gates CRISPR

Intellia dabbles in RNA therapeutics

Intellia dabbles in RNA therapeutics

Ark Invest 2023 Big Ideas on CRISPR

Ark Invest 2023 Big Ideas on CRISPR

World CRISPR Cancer Day

World CRISPR Cancer Day

Back in a Bull Run

Back in a Bull Run

Why Partnerships Matter in CRISPR

Why Partnerships Matter in CRISPR

Doudna says CRISPR will Defeat Climate Change

Doudna says CRISPR will Defeat Climate Change

Ginkgo In Trouble?

Ginkgo In Trouble?

Markets Bull Run?

Markets Bull Run?

SANA FDA Approval

SANA FDA Approval

Editas Medicine CRISPR Updates

Editas Medicine CRISPR Updates

Next 10 years of CRISPR by Doudna

Next 10 years of CRISPR by Doudna

Prime Medicine Bull Case

Prime Medicine Bull Case

Intellia is the leading CRISPR company

Intellia is the leading CRISPR company

BEAM CEO Interview

BEAM CEO Interview

BEAM Tx Updates

BEAM Tx Updates

EU & UK Moves Forward with CRISPR Tx

EU & UK Moves Forward with CRISPR Tx

Intellia Tx Updates 2023 & 2024

Intellia Tx Updates 2023 & 2024

People are afraid to use the word "CRISPR"

People are afraid to use the word "CRISPR"

Graphite Bio is in Trouble

Graphite Bio is in Trouble

Elon Musk Tweets at CRISPR

Elon Musk Tweets at CRISPR

TIME Covers CRISPR

TIME Covers CRISPR

All Eyes on CRISPR CTX001

All Eyes on CRISPR CTX001

2023 is All About CRISPR

2023 is All About CRISPR

CRISPR Slays Diseases For the First Time Ever

CRISPR Slays Diseases For the First Time Ever

Three CRISPR Companies Dominate Ark Invest Portfolio

Three CRISPR Companies Dominate Ark Invest Portfolio

Phase 1/2/3 of CRISPR Trials

Phase 1/2/3 of CRISPR Trials

CRISPR Mentioned by the All-In Podcast

CRISPR Mentioned by the All-In Podcast

Caribou CB-010 Updates

Caribou CB-010 Updates

Happy Holidays to All!

Happy Holidays to All!

Base Editing Is The Future

Base Editing Is The Future

Let's Talk About The Markets

Let's Talk About The Markets

CRISPR Moves Humanity Forward

CRISPR Moves Humanity Forward

Base Editing CRISPR Cured Patient

Base Editing CRISPR Cured Patient

Mammoth Prepares IPO

Mammoth Prepares IPO

Leadership & Investing

Leadership & Investing

FDA Responds to VERV

FDA Responds to VERV

CRISPR Scientist Released

CRISPR Scientist Released

FDA Lifts Off BEAM Hold

FDA Lifts Off BEAM Hold

$NTLA Dillution

$NTLA Dillution

Intellia Therapeutics Overview

Intellia Therapeutics Overview

BEAM Drama

BEAM Drama

A Video on Mammoth

A Video on Mammoth

Caribou is Winning

Caribou is Winning

Editas is in TROUBLE

Editas is in TROUBLE

Dr. Liu Speaks out on FDA

Dr. Liu Speaks out on FDA

CRISPR $1T

CRISPR $1T

BEAM Updates

BEAM Updates

BEAM Enrolls First Patient

BEAM Enrolls First Patient

Intellia is Winning (NTLA-2002)

Intellia is Winning (NTLA-2002)

This Past Week Has Been Hectic

This Past Week Has Been Hectic

Markets are Crazy

Markets are Crazy

CEO VERV Strikes Back

CEO VERV Strikes Back

FDA Stops VERV

FDA Stops VERV

Huge Life Event

Huge Life Event

CRISPR Rankings

CRISPR Rankings

Thoughts on the FDA regarding CRISPR

Thoughts on the FDA regarding CRISPR

FDA Guidance on Genome Editing

FDA Guidance on Genome Editing

Verv Drama Continues

Verv Drama Continues

Verv Hiding Something?

Verv Hiding Something?